Skip To Main Content
Ellen Barendorff on Muck Rack

Ellen Barendorff

As seen in: Arthritis Research & Therapy
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ellen

Contact Ellen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The dual amylin and calcitonin receptor agonist KBP-336 elicits a unique combination of weight loss, antinociception and bone protection - a novel disease-modifying osteoarthritis drug | Arthritis Research & Therapy | Full Text

|
By Morten Asser, Khaled Elhady, Anna Thorsø, Ellen Barendorff
| Arthritis Research & Therapy Verified
References Steinmetz JD, Culbreth GT, Haile LM, Rafferty Q, Lo J, Fukutaki KG et al. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol [Internet]. 2023 Sep 1 [cited 2023 Sep 28];5(9):e508–22. http://www.thelancet.com/article/S2665991323001637/fulltext. Martel-Pelletier J, Barr AJ, Cicuttini FM, Conaghan PG, Cooper C, Goldring MB, et al. Osteoarthr Nat Rev Dis Primers.
Open in Who Shared Issue with article?
See all 1 articles